WTB RSS
03-29-2012, 01:29 PM
•    Shares of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN ) gained 54.45% after Bloomberg reported  that the diabetes drug maker had rejected a $3.5 http://feedads.g.doubleclick.net/~a/ERtYIiz_c8dfnD36lnW9RihsEM8/0/di (http://feedads.g.doubleclick.net/~a/ERtYIiz_c8dfnD36lnW9RihsEM8/0/da)
http://feedads.g.doubleclick.net/~a/ERtYIiz_c8dfnD36lnW9RihsEM8/1/di (http://feedads.g.doubleclick.net/~a/ERtYIiz_c8dfnD36lnW9RihsEM8/1/da)
http://feeds.feedburner.com/~r/nasdaq/categories/~4/vyHexIeCRnc
More... (http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/vyHexIeCRnc/company-news-for-march-29-2012-corporate-summary.aspx)
http://feedads.g.doubleclick.net/~a/ERtYIiz_c8dfnD36lnW9RihsEM8/1/di (http://feedads.g.doubleclick.net/~a/ERtYIiz_c8dfnD36lnW9RihsEM8/1/da)
http://feeds.feedburner.com/~r/nasdaq/categories/~4/vyHexIeCRnc
More... (http://articlefeeds.nasdaq.com/~r/nasdaq/categories/~3/vyHexIeCRnc/company-news-for-march-29-2012-corporate-summary.aspx)